Introduction
In the current review we would like to give our comments on Preeclampsia, eclampsia and HELLP syndrome affect many women and lead to a high percentage of maternal and perinatal complications [1] . It is important for clinicians to accurately diagnose the conditions to prevent any adverse outcome. In most cases, classic presentation with hypertension and proteinuria in pregnancy>20 g.w. is observed. However, recent studies show that some women develop preeclampsia without showing any classic symptoms. Atypical cases are those that may develop before 20g.w. or with signs and symptoms of preeclampsia without hypertension or proteinuria, or those with mild abnormalities in laboratory tests [2] .
In the countries of South America and those in the Caribbean hypertensive disorders account for almost 26% of deaths among mothers, while in Africa and Asia contribute about 9% of deaths [3] . 
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Although maternal mortality is significantly lower in high-income countries than in developing countries, 16% of maternal mortality may be due to hypertensive disorders. In the United States, the rate of preeclampsia has increased by 25% between 1987 and 2004 [4] .
Moreover, compared to women who gave birth in 1980, those who gave birth in 2003 were 6.7 times more likely to have complications from severe preeclampsia. Treatment of preeclampsia requires many resources: for example, in 2016 in the United States treatment cost of preeclampsia during the first 12 months after delivery are worth 2.18 billion dollars (1.03 billion dollars for women and 1.15 billion dollars for new borns together).
Data from Practice Bulletin of the American College of Obstetrics and Gynaecologists 2019
Recommendations for Therapeutic Strategy in Gestational Hypertension/ Preeclampsia a) In women with gestational hypertension or preeclampsia at 37 weeks gestation or later without severe pathology delivery is recommended. Those guidelines show that the range for normal blood pressure of not pregnant women has a lower threshold for diagnosis of hypertension in comparison with the criteria of ACOG. This is likely to lead to an overall increase in patients classified with chronic hypertension and will require co-decision by the obstetrician and cardiologist, as well as by the patient regarding appropriate guideline during pregnancy [5] .
Recommendations for Therapeutic Strategy in Chronic Hypertension

Summary of the most important recommendations of the Working Group on Hypertension in Pregnancy:
a) Careful and complete patient's history taking to assess risk factors. According to the report of the working group on ACOG of hypertension in pregnancy the diagnosis preeclampsia still requires quantitative measurement of protein in urine. The work group recommends that clinicians should also consider other factors, in addition to high blood pressure to diagnose preeclampsia without delay [6] .
The incidence of preeclampsia in the USA has markedly increased with 25% over the past two decades and it is the leading cause of maternal and neonatal morbidity and mortality. Preeclampsia is a serious condition that usually begins after 20 g.w., and high arterial pressure is a major factor. Women who have chronic hypertension and have had preeclampsia during a previous pregnancy of 35 years or more, who have more than one fetus, have diabetes or renal disease, are with obesity, Afro-American have an autoimmune disorders are at increased risk of developing of pre-eclampsia. Signs of preeclampsia include severe headache, vision disorders, rapid weight gain, abdominal pain and swelling.
Definitive treatment of preeclampsia is delivery [7] . 
Conclusion
Hypertensive disorders in pregnancy are one of the most fre- 
